HEALIOS K.K. Logo

HEALIOS K.K.

4593 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
千代田区有楽町一丁目7番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HEALIOS K.K. is a pioneering Japanese biotechnology company focused on the research and development of innovative cell therapies and regenerative medicine. With a commitment to addressing serious and life-threatening diseases, HEALIOS leverages advanced technologies to create effective treatments for conditions with limited or no existing therapies. The company has received Fast Track and RMAT designations, expediting the approval process for its groundbreaking cellular products. HEALIOS is dedicated to advancing solutions for critical health challenges, including cancers such as mesothelioma, lung cancer, hepatocellular carcinoma, as well as retinal pigment epithelium disorders, thereby contributing to the future of healthcare.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for HEALIOS K.K.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-13 08:33
Regulatory News Service
臨時報告書
Japanese 19.7 KB
2025-03-27 07:22
Regulatory News Service
臨時報告書
Japanese 25.4 KB
2025-03-27 07:21
Regulatory News Service
確認書
Japanese 8.1 KB
2025-03-27 07:20
Regulatory News Service
内部統制報告書-第14期(2024/01/01-2024/12/31)
Japanese 21.7 KB
2025-03-27 07:19
Annual Report
有価証券報告書-第14期(2024/01/01-2024/12/31)
Japanese 2.0 MB
2025-02-14 05:13
Regulatory News Service
訂正臨時報告書
Japanese 37.5 KB
2025-02-14 04:07
Regulatory News Service
臨時報告書
Japanese 21.3 KB
2025-01-27 07:31
Prospectus
有価証券届出書(参照方式)
Japanese 224.3 KB
2025-01-22 07:33
Regulatory News Service
臨時報告書
Japanese 53.3 KB
2024-11-13 07:34
Regulatory News Service
臨時報告書
Japanese 20.0 KB
2024-08-13 08:04
Regulatory News Service
臨時報告書
Japanese 19.9 KB
2024-08-13 08:04
Regulatory News Service
確認書
Japanese 8.2 KB
2024-08-13 08:03
Interim Report
半期報告書-第14期(2024/01/01-2024/12/31)
Japanese 402.0 KB
2024-05-13 09:22
Regulatory News Service
臨時報告書
Japanese 19.9 KB
2024-05-13 09:21
Regulatory News Service
確認書
Japanese 8.2 KB

Automate Your Workflow. Get a real-time feed of all HEALIOS K.K. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HEALIOS K.K. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK